Skip to main content
Methotrexate
In this session, Dr. Jack Cush reviews methotrexate.
Preoperative Semaglutide for 3 mos. prior to Total Knee Arthroplasty assoc w/ signif less Postoperative Adverse Events i

Dr. John Cush RheumNow

6 months 1 week ago
Preoperative Semaglutide for 3 mos. prior to Total Knee Arthroplasty assoc w/ signif less Postoperative Adverse Events in NIDDM. Retrospective study of up to 745 T2DM needed TKR . 2-3 mos of GLP-1a reduces serious AEs by 75% (OR 0.25, P < 0.001). https://t.co/re57y9OvTN https://t.co/KNirmfdr2F
This week’s RheumNow Live pre-Learn spotlight: Vasculitis & Autoimmune disease.

We’re diving into this importan

Dr. John Cush RheumNow

6 months 1 week ago
This week’s RheumNow Live pre-Learn spotlight: Vasculitis & Autoimmune disease. We’re diving into this important topic with expert-led talks from Drs. Nancy Olsen, Matthew Baker, and Clay Cockerell. To help you get the most out of their sessions, our speakers have shared key https://t.co/zLKY52Fi17
Medicare Primary Care Shortage - betw 2013 -2021, PCPs decr 25%, while APPs rose 91%.2021 AVAILABILITY per 10,000 Medi

Dr. John Cush RheumNow

6 months 1 week ago

Medicare Primary Care Shortage - betw 2013 -2021, PCPs decr 25%, while APPs rose 91%. 2021 AVAILABILITY per 10,000 Medicare beneficiaries; - Total clinicians: 23.4 to 22.2 (–5%) - Total new visits: 1162 to 1102 (–5%) - Total PCPs: 20.0 to 15.5 (–22%) - APPs: 3.4 to 6.7 (+97%) https://t.co/ALQI3O3Ian

Emergency Department Visits by Rheumatoid Patients

A Canadian population study shows that rheumatoid arthritis (RA) pa

Dr. John Cush RheumNow

6 months 1 week ago
Emergency Department Visits by Rheumatoid Patients A Canadian population study shows that rheumatoid arthritis (RA) patients have 30% higher emergency department (ED) visit rates for Ambulatory Care Sensitive Conditions (ACSCs) compared to age- and sex-matched population https://t.co/BL8AkXhkFG
Smartphones and Rheumatoid Flares

FORWARD Databank of Rheumatoid arthritis (RA) patients reveals that smartphone data

Dr. John Cush RheumNow

6 months 1 week ago
Smartphones and Rheumatoid Flares FORWARD Databank of Rheumatoid arthritis (RA) patients reveals that smartphone data can predict flares using PROs. https://t.co/xy6uqsQNt2 https://t.co/JwZlOLco6V
Rheum Survey> 40 yoF RA pt on Prednisone 5 mg/d is at increased risk for ?

Dr. John Cush RheumNow

6 months 1 week ago
Rheum Survey> 40 yoF RA pt on Prednisone 5 mg/d is at increased risk for ?
Are JAK Inhibitors Better at Pain Relief in RA?
  • MedPage Today
Among rheumatoid arthritis (RA) patients responding to upadacitinib (Rinvoq) or adalimumab, those receiving the former had significantly less residual pain with treatment, according to a post-hoc analysis of phase III trial data.
JAMA has published a full read review of RLS - restless leg syndrome - a frequent, but often unrecognized, cause of poor sleep and the resultant hazards of insomnia.
Nurse Practitioner Independence

A JAMA Viewpoint article reports on a March 2025 Nurse Practitioner (NP) Entrepreneurs

Dr. John Cush RheumNow

6 months 1 week ago
Nurse Practitioner Independence A JAMA Viewpoint article reports on a March 2025 Nurse Practitioner (NP) Entrepreneurship Summit in Boston in March 2025 identifying barriers and opportunities to NP-owned medical practices. https://t.co/rkzLwhnNYh https://t.co/bxJWptPQK9
2024 Cardiology Income Survey - CV APP salary has incr 15% from 2019 -23, median=$123K- 50% of APP programs lead by an

Dr. John Cush RheumNow

6 months 1 week ago

2024 Cardiology Income Survey - CV APP salary has incr 15% from 2019 -23, median=$123K - 50% of APP programs lead by an APP >90% work in outpt. clinics - 2/3 of prgs deploy APPs lipid & prevention management - 2 APPs for every 3 cardiologists https://t.co/gtdm5qN1qD https://t.co/cx2JUcw4U3

German psoriasis registry PsoBest reports on 595 Rx w/ apremilast (417 APR monotherapy). Compared to Ptx Rx w/ other DMA

Dr. John Cush RheumNow

6 months 1 week ago
German psoriasis registry PsoBest reports on 595 Rx w/ apremilast (417 APR monotherapy). Compared to Ptx Rx w/ other DMARDs/biologic drugs, APR pts higher age, more comorbidities. Nonserious AEs: ineffectiveness (14%), diarrhea (9%), nausea (7%), HA (6%). https://t.co/TviJmM7Fr9 https://t.co/tY89oHgUgV
×